Analysis and Mathematical Modelling of IAV DIP Replication


Defective interfering particles (DIPs) are composed similarly to influenza A virus (IAV) particles, but they contain an internal deletion in one of their eight viral genome segments. Thus, DIP replication is defective and dependent on co-infection with infectious standard virus (STV). During co-infection, they inhibit replication and packaging of the STV, and induce an antiviral state. Therefore, they are considered as a new class of antiviral drugs.

Aim of the project

As the complex interplay between DIPs and STVs is not yet fully resolved, we investigate the IAV infection dynamics experimentally to establish a novel multiscale model, which describes the DIP/STV replication at the intracellular and extracellular level (Fig. 1). To analyze the time-resolved replication dynamics, we conduct infection experiments for a broad range of STV and DIP concentrations in parallel. For this, a reverse genetics approach was used to generate a helper-virus free segment 1 (S1)-derived DIP seed using a cell line complementing the non-functional polymerase basic protein 2 (PB2) of S1.

The analysis of IAV and DIP replication in a co-infection includes the measurement of extracellular and intracellular viral RNA concentrations by real-time RT-qPCR. Moreover, imaging cytometry is used to provide detailed insights into the status of infection such as the fraction of infected cells and apoptosis. Based on this quantitative and qualitative data, an unprecedented level of detail and resolution is available to validate our mathematical model of DIP replication. This model will support the optimization of cell-culture based DIP production and allow the investigation of critical factors in antiviral therapy, such as the required DIP to STV concentration. Eventually, this model may be further extended to describe the tissue, or even organism level in the future.


Rüdiger, D.; Piasecka, J.; Küchler, J.; Pontes, C.; Laske, T.; Kupke, S. Y.; Reichl, U.: Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”. iScience 27 (4), 109421 (2024)
Rüdiger, D.; Pelz, L.; Hein, M. D.; Kupke, S. Y.; Reichl, U.: Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture. PLoS Computational Biology 17, e1009357 (2021)
Bdeir, N.; Arora, P.; Gärtner, S.; Hoffmann, M.; Reichl, U.; Pöhlmann, S.; Winkler, M.: A system for production of defective interfering particles in the absence of infectious influenza A virus. PLoS One 14 (3), e0212757 (2019)
Laske, T.; Heldt, F. S.; Hoffmann, H.; Frensing, T.; Reichl, U.: Modeling the intracellular replication of influenza A virus in the presence of defective interfering RNAs. Virus Research 213, pp. 90 - 99 (2016)
Heldt, S.; Frensing, T.; Pflugmacher, A.; Gröpler, R.; Peschel, B.; Reichl, U.: Multiscale Modeling of Influenza A Virus Infection Supports the Development of Direct-Acting Antivirals. PLoS Computational Biology 9 (11), p. e1003372 (2013)
Frensing, T.; Heldt, S.; Pflugmacher, A.; Behrendt, I.; Jordan, I.; Flockerzi, D.; Genzel, Y.; Reichl, U.: Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles. PLoS One 8 (9), p. e72288 (2013)
Go to Editor View